Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Baudin

Showing results (71-80 of 129) with videos related to

Pageof 13
Sort By:
European Journal of Endocrinology|October 25, 2012
Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapyG Hajje, I Borget, S Leboulleux, et al.
European Journal of Endocrinology|October 6, 2010
Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancyS Leboulleux, D Deandreis, C Escourrou, et al.
Hepato-Gastroenterology|November 10, 2004
Prognostic factors for chemoembolization in liver metastasis from endocrine tumorsA Roche, B V Girish, T de Baere, et al.
Gastroenterologie Clinique Et Biologique|April 12, 2008
[Verner-Morrison syndrome revealing a ganglioneuroblastoma in an adult]C Neuzillet, P Hammel, E Baudin, et al.
European Journal of Endocrinology|February 15, 2001
Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumorsN Boulle, E Baudin, C Gicquel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2017
Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 studyM E Pavel, E Baudin, K E Öberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2019
Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 studyM E Pavel, E Baudin, K E Öberg, et al.
Cancer|August 5, 1998
Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experienceE Baudin, J P Travagli, J Ropers, et al.
European Journal of Endocrinology|August 14, 2013
Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablationC Nascimento, I Borget, F Troalen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2020
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upM Fassnacht, G Assie, E Baudin, et al.
Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
European Journal of Endocrinology|October 25, 2012
Early changes in carcinoembryonic antigen but not in calcitonin levels are correlated with the progression-free survival in medullary thyroid carcinoma patients treated with cytotoxic chemotherapyG Hajje, I Borget, S Leboulleux, et al.
European Journal of Endocrinology|October 6, 2010
Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancyS Leboulleux, D Deandreis, C Escourrou, et al.
Hepato-Gastroenterology|November 10, 2004
Prognostic factors for chemoembolization in liver metastasis from endocrine tumorsA Roche, B V Girish, T de Baere, et al.
Gastroenterologie Clinique Et Biologique|April 12, 2008
[Verner-Morrison syndrome revealing a ganglioneuroblastoma in an adult]C Neuzillet, P Hammel, E Baudin, et al.
European Journal of Endocrinology|February 15, 2001
Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumorsN Boulle, E Baudin, C Gicquel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2017
Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 studyM E Pavel, E Baudin, K E Öberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2019
Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 studyM E Pavel, E Baudin, K E Öberg, et al.
Cancer|August 5, 1998
Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experienceE Baudin, J P Travagli, J Ropers, et al.
European Journal of Endocrinology|August 14, 2013
Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablationC Nascimento, I Borget, F Troalen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 31, 2020
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-upM Fassnacht, G Assie, E Baudin, et al.
Pageof 13